Robuta

Sponsor of the Day: Jerkmate
https://reports.statnews.com/collections/all-reports/products/treating-depression-report Treating Depression: A new era of promising drugs | STAT Reports STAT’s latest report details the challenges, possibilities and frontrunners in the race to remake treatment of the world’s most common mental health problem. treating depressionnew eradrugs statpromisingreports https://www.statnews.com/2025/10/06/telehealth-companies-shift-from-providing-patient-access-to-selling-drugs/ Telehealth companies shifting from access to care to selling drugs | STAT Mar 12, 2026 - Telehealth began as a way to help patients access doctors, but has rapidly transformed into a way to help companies sell drugs. A STAT special report by Katie... telehealth companiesselling drugsshiftingaccesscare https://www.statnews.com/2019/04/29/y-combinator-startups-small-molecule-drugs/ Y Combinator to fund more startups pursuing small-molecule drugs | STAT Jul 25, 2023 - In a Silicon Valley twist, the compounds Y Combinator is backing will often be recommended by an algorithm designed to identify promising drug candidates. small moleculedrugs statcombinatorfundstartups https://www.statnews.com/2025/11/06/trumprx-weight-loss-drug-discounts-wegovy-zepbound/ TrumpRx to offer discount weight loss drugs after Lilly, Novo deals | STAT Nov 6, 2025 - Novo Nordisk's Wegovy, Eli Lilly's Zepbound to be sold at discounted prices on TrumpRx, covered by Medicare under new Trump deal. weight loss drugsoffer discountlilly novotrumprxdeals https://www.statnews.com/2025/06/23/glp-1-drug-helped-type-1-diabetes-patients-keep-healthy-glucose-levels-and-lose-weight/ GLP-1 drugs effective for type 1 diabetes in new study| STAT Jun 24, 2025 - Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. glp 1 drugstype diabetesnew studyeffectivestat https://www.statnews.com/2024/05/23/weight-loss-drugs-rna-interference-gene-silencing-regeneron/ For longer-lasting obesity drugs, biotechs turn to gene silencing | STAT May 24, 2024 - As shown in STAT’s Obesity Drug Tracker, Regeneron and others are using RNA interference to target genetics, rather than hormones like GLP-1. longer lastingobesity drugsgene silencingbiotechsturn https://reports.statnews.com/collections/all-reports/products/the-obesity-revolution-how-glp-1-drugs-are-changing-society The Obesity Revolution: How GLP-1 drugs are changing science, business | STAT Reports STAT's latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society.... glp 1 drugschanging sciencestat reportsobesityrevolution https://www.statnews.com/topic/drug-prices/ STAT Drug Prices - The Cost Issues of Prescription Drugs News and analysis on drug prices. Read about the rising cost of prescription drugs, the impact on the healthcare system and efforts to lower costs. stat drugprescription drugspricescostissues https://www.statnews.com/2025/06/17/weight-loss-drugs-glp-1s-agency-health-reframing-motivation/ Weight-loss drugs offer patients the power to change | STAT Health isn’t just the sum of your metrics. It’s also the experience of living with purpose and possibility. weight loss drugsofferpatientspowerchange https://www.statnews.com/2025/06/05/glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration/ GLP-1 drugs may be linked to higher risk of eye disease: study | STAT Jun 6, 2025 - A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't. glp 1 drugshigher riskeye diseasestudy statmay https://www.statnews.com/topic/obesity/page/2/ STAT Obesity - New Weight Loss Drugs Change Diet Landscape Groundbreaking news and analysis about obesity and a new generation of weight-loss drugs, including Ozempic, Wegovy and Mounjaro. new weight lossstatobesitydrugschange https://www.statnews.com/2026/02/06/white-house-wants-more-pharma-companies-on-trumprx/ White House wants to add more drugs to TrumpRx | STAT Feb 6, 2026 - The Trump administration is working to get more companies to offer prescription drugs at discounted cash prices on TrumpRx. white house wantstrumprx statadddrugs https://www.statnews.com/2026/01/28/how-gas-station-drugs-remain-legal/ 'Gas station drugs' are everywhere. How long will they remain legal? | STAT This week’s STATus Report digs into how and why gas stations became the perfect marketplace for quasi-legal gas stationdrugseverywherelongremain https://www.statnews.com/2026/03/19/antipsychotic-drug-misuse-nursing-homes-hhs-oig-reports/ HHS watchdog details misuse of antipsychotic drugs in nursing homes | STAT Federal watchdog says nursing homes use antipsychotic drugs as 'chemical restraints' on dementia patients, disguise practice as schizophrenia treatment. antipsychotic drugsnursing homeshhswatchdogdetails https://www.statnews.com/topic/obesity/ STAT Obesity - New Weight Loss Drugs Change Diet Landscape Groundbreaking news and analysis about obesity and a new generation of weight-loss drugs, including Ozempic, Wegovy and Mounjaro. new weight lossstatobesitydrugschange https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/ Weight loss drugs on the horizon: STAT's Obesity Drug Tracker Jun 17, 2025 - Our database tracks the new weight loss drugs that could hit the market, novel mechanisms, and which companies are in the hunt. weight loss drugshorizonstatobesitytracker https://www.statnews.com/topic/psychedelics/ Psychedelic Drugs: Coverage of the Latest Medical News - STAT Stay up to date on the latest news and research on using psychedelic drugs to treat mental illness, including depression, anxiety and PTSD. latest medical newspsychedelic drugscoveragestat https://www.statnews.com/2026/04/21/tortugas-neuroscience-jiangsu-hansoh-eisai/ Tortugas Neuroscience will develop drugs for brain disorders | STAT The biotech startup, financed with $106 million from Cure Ventures and other firms, has licensed therapies from China’s Jiangsu Hansoh and Japan’s Eisai. brain disorderstortugasneurosciencedevelopdrugs https://reports.statnews.com/collections/all-reports/products/the-obesity-revolution-how-glp-1-drugs-are-changing-society?variant=40497160257639 The Obesity Revolution: How GLP-1 drugs are changing science, business | STAT Reports STAT's latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society.... glp 1 drugschanging sciencestat reportsobesityrevolution https://www.statnews.com/2024/09/05/obesity-drug-tracker-amylin-weight-loss-drugs-novo-nordisk-eli-lilly-zealand-pharma/ Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound? | STAT Sep 5, 2024 - Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects. obesity drugwegovy zepboundtrackeramylindrugs https://www.statnews.com/pharmalot/2026/04/16/alzheimers-drugs-review-fda-panel-for-compounded-peptides/ Pharmalittle: Alzheimer's drugs reviewed, FDA panel to vet peptides | STAT Apr 16, 2026 - A new report released by Senate Democrats finds that prescription drug prices have continued to climb — in some cases, sharply. pharmalittlealzheimerdrugsreviewedfda